Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer: Robert Friel, Prahlad Singh, Alexis Michas

After serving 12 years as CEO of PerkinElmer, Robert Friel will step down from that position as well as from his role as chairman of the board, effective Dec. 29, 2019. He will continue to serve as an advisor until March 1, 2020. The firm also announced that Prahlad Singh, current president and COO of PerkinElmer, will become CEO on Dec. 30, 2019, and he has been elected a director of the company, effective today. Prior to joining PerkinElmer in 2014, Singh was general manager of GE Healthcare's women's health business.

PerkinElmer also said that Alexis Michas, currently lead director, will serve as non-executive chairman of PerkinElmer's board, starting Dec. 30.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.